Cite
HARVARD Citation
Hagberg, K. et al. (2016). Does Angiotensin‐Converting Enzyme Inhibitor and β‐Blocker Use Reduce the Risk of Primary Liver Cancer? A Case–Control Study Using the UK Clinical Practice Research Datalink. Pharmacotherapy. 36 (2), pp. 187-195. [Online].